Clinical trial
Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured…
NCT00221689 · University Hospital, Bordeaux, Other · Terminated
Key facts
| NCT number | NCT00221689 |
|---|---|
| Title | Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients |
| Official title | Early Treatment of Paroxysmal Dysautonomia and Hypertonia for Severe Brain Injured Patients by Intrathecal Baclofen Therapy |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Ministry of Health, France |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury, Cerebral Anoxia, Coma, Hypertonia, Dysautonomia |
| Intervention type | Drug |
| Interventions | baclofen (drug) |
| Enrollment | 4 |
| Start date | Mar 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 13, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: